TRADENAME: MITOG

ACTIVE PRINCIPLE: Oxaliplatin

PRESENTATIONS FOR SALE:

50 mg x 1 Fco. Amp.

100 mg x 1 Fco. Amp.

THERAPEUTIC ACTION: Treatment of metastatic rectal colon cancer after previous treatment with fluorpyrimidines with monochemotherapy or associated.